Innospec (OCT) AI Stock Analysis
Innospec
(Frankfurt:OCT)
No summary available
Innospec (OCT) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 2.46B
- Dividend Yield
- 1.75%
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- 20.3
- Beta (1Y)
- 0.57
- Revenue Growth
- -4.15%
- EPS Growth
- 544.78%
- Country
- Germany
- Employees
- 2,450
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Innospec Business Overview & Revenue Model
Company Description
Innospec Inc., founded in 1938 as Octel Corp. and rebranded in January 2006, is a global company headquartered in Englewood, Colorado. It focuses on the creation, production, formulation, promotion, and distribution of unique chemical products. The c...
Innospec Earnings Call Summary
The call presented a predominantly positive operational and financial picture: double-digit revenue growth, strong segment operating income gains (notably oilfield services and performance chemicals), no debt and $250M+ cash, and continued shareholder returns. Key challenges remain from earlier supply disruptions that constrained volumes, some margin compression (particularly in Fuel Specialties) and near-term cash conversion where capex exceeded operating cash in the quarter. Management provided clear remediation plans (plant repairs ~60% complete, expected full optimization by end-Q4 and >10% capacity upside), and guided to further operating income improvement in the second half, suggesting these challenges are being managed and that momentum should improve.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management guided to further operating‑income growth in the second half of fiscal 2026 for Performance Chemicals and Oilfield Services, with Fuel Specialties expected to deliver a steady performance (Q2 revenues: Performance Chemicals $190.3M, gross margin 17.3%, operating income $16.4M; Fuel Specialties $185.7M, gross margin 36.6%, operating income $36.3M; Oilfield Services $115.4M, gross margin 32.3%, operating income $8.7M). They expect Performance Chemicals plant repairs and optimizations to be complete by end‑Q4 with potential capacity upside “north of 10%” into next year, DRA capacity largely sold out with another expansion under discussion, and sequential improvement in Oilfield Services across 2H26; Fuel Specialties may see some Q3 margin headwind from the lag between pricing and raw‑material inflation but remains in its target margin range. On the balance sheet/cash flow side management highlighted Q2 operating cash flow of $7.2M before $16.5M of capex, cash and equivalents of $250.2M with no debt, continued capital returns (semi‑annual dividend $0.92/share and $6.4M of buybacks in Q2), and an expectation that working‑capital improvements will support increased operating cash flow in 2H26.
Innospec Risk Analysis
Innospec disclosed 28 risk factors in its most recent earnings report. Innospec reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
0 New RisksInnospec Peers Comparison
Overall Rating
FUL68Neutral
SCL61Neutral
KWR60Neutral
NGVT58Neutral
ASH56Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| FUL | 68Neutral | $2.68B | 13.65 | 9.51% | 1.95% | 1.48% | 72.33% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| SCL | 61Neutral | $1.58B | 366.37 | 0.36% | 2.27% | 10.02% | -90.50% |
| KWR | 60Neutral | $2.60B | 26.86 | 7.02% | 1.36% | 8.68% | ― |
| NGVT | 58Neutral | $2.55B | 48.26 | 85.17% | ― | -12.42% | ― |
| ASH | 56Neutral | $3.42B | 65.51 | 2.77% | 2.24% | -1.39% | ― |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:OCT | Innospec | 89.00 | 27.01 | 43.56% | |
| ASH | Ashland Global Holdings, Inc. | 74.68 | 27.76 | 59.17% | |
| FUL | H.B. Fuller Company | 49.70 | -6.72 | -11.91% | |
| KWR | Quaker Chemical | 150.95 | 19.66 | 14.98% | |
| SCL | Stepan Company | 69.61 | 28.35 | 68.72% | |
| NGVT | Ingevity | 74.32 | 20.48 | 38.04% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.